INVITATION TO INVESTOR MEETING Stockholm, Sweden, August 26, 2008 Elekta is pleased to invite analysts and investors to an investor meeting held in conjunction with the meeting of ASTRO (American Society for Therapeutic Radiology and Oncology) in Boston, USA. Elekta will provide information about its current focus areas and product portfolio. Elekta's President and CEO Tomas Puusepp, Dee Mathieson, SVP Business Line Management Oncology Systems, and Jay Hoey, EVP Software Systems, will participate in this meeting. Date and time: Monday September 22, from 2 p.m. to approximately 4 p.m. (EDT). Location: Renaissance Boston Waterfront Hotel, Pacific Salon, 606 Congress Street. This hotel is conveniently located across the street from the Boston conference center. For more information, please see www.renaissanceboston.com. Investors and analysts who want to attend this meeting are kindly requested to give notice by e-mail to ir@elekta.com at the latest September 15. The meeting will be broadcasted over the Internet (audio and synchronized slides). Please visit www.elekta.com - Investors, or use the direct link: http://wcc.webeventservices.com/view/wl/r.htm?e=117622&s=1&k=E4C9ADAD664CF3DD6EA 2118DB5DE766A&cb=genesys It will also be possible to listen to the meeting via telephone. It will however not be possible to ask questions via the telephone conference. Call-in numbers for teleconference, September 22 at 2 p.m. EDT UK: +44 (0)20 7162 0025 US: +1 334 323 6201 Norway: +47 2156 31 20 France: +33 (0)1 7099 3208 Germany: +49 (0)695 8999 0507 Netherlands: +31 (0)20 7965 008 Sweden: +46 (0)8 5052 0110 Denmark: +45 3271 4607 Switzerland (Geneva): +41 (0)2 2592 7007 Switzerland (Zurich): +41 (0)434 5692 61 Please note that for local connect dial-in numbers it may be required to dial the area code to enter the conference. The telephone conference will be available afterwards on instant replay for seven days. Please dial UK +44 (0)207 031 40 64, Sweden +46 (0) 8 505 203 33, US +1 954 334 0342 and use access code 807653. For further information, please contact: Lena Schattauer, Investor Relations Tel: +46 70 595 51 00 (mobile), e-mail: lena.schattauer@elekta.com About Elekta Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight serious disease. Elekta provides advanced clinical solutions, comprehensive management and information systems as well as services for improved cancer care and management of brain disorders. Elekta's systems and solutions are used in over 5,000 hospitals around the world. Clinical and information management solutions include, among others, Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR and efficient management of clinical and patient data. With around 2,500 employees globally, the corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information about Elekta can be found at www.elekta.com.
INVITATION TO INVESTOR MEETING
| Source: Elekta AB
Attachments
